These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1929879)

  • 1. Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor.
    Schätzl H; Gelderblom HR; Nitschko H; von der Helm K
    Arch Virol; 1991; 120(1-2):71-81. PubMed ID: 1929879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the retroviral HIV-proteinase impairs maturation to infectious human immunodeficiency virus (HIV).
    Nitschko H; Schätzl H; Gelderblom HR; Oswald M; von der Helm K
    Biomed Biochim Acta; 1991; 50(4-6):655-8. PubMed ID: 1801738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A C2 symmetry-based HIV protease inhibitor, A77003, irreversibly inhibits infectivity of HIV-1 in vitro.
    Kageyama S; Hoekzema DT; Murakawa Y; Kojima E; Shirasaka T; Kempf DJ; Norbeck DW; Erickson J; Mitsuya H
    AIDS Res Hum Retroviruses; 1994 Jun; 10(6):735-43. PubMed ID: 8074936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.
    Ashorn P; McQuade TJ; Thaisrivongs S; Tomasselli AG; Tarpley WG; Moss B
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7472-6. PubMed ID: 2217178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    McQuade TJ; Tomasselli AG; Liu L; Karacostas V; Moss B; Sawyer TK; Heinrikson RL; Tarpley WG
    Science; 1990 Jan; 247(4941):454-6. PubMed ID: 2405486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
    Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC
    EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphology.
    Humphrey RW; Ohagen A; Davis DA; Fukazawa T; Hayashi H; Höglund S; Mitsuya H; Yarchoan R
    Antimicrob Agents Chemother; 1997 May; 41(5):1017-23. PubMed ID: 9145862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
    Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
    AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.
    Shehu-Xhilaga M; Hill M; Marshall JA; Kappes J; Crowe SM; Mak J
    J Virol; 2002 May; 76(9):4331-40. PubMed ID: 11932399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV by an anti-HIV protease synthetic peptide blocks an early step of viral replication.
    Venaud S; Yahi N; Fehrentz JL; Guettari N; Nisato D; Hirsch I; Chermann JC
    Res Virol; 1992; 143(5):311-9. PubMed ID: 1480823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    Dis Markers; 1990; 8(3):162-3. PubMed ID: 2125537
    [No Abstract]   [Full Text] [Related]  

  • 13. A human cell line constitutively expressing HIV-1 Gag and Gag-Pol gene products.
    Wang CT; Li JJ; Lai HY; Hu BS
    J Med Virol; 1999 Jan; 57(1):17-24. PubMed ID: 9890417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of protease inhibitors on HIV-1 maturation and infectivity.
    Jardine DK; Tyssen DP; Birch CJ
    Antiviral Res; 2000 Jan; 45(1):59-68. PubMed ID: 10774590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein.
    Rayner MM; Cordova BC; Meade RP; Aldrich PE; Jadhav PK; Ru Y; Lam PY
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1635-40. PubMed ID: 7979297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells.
    Mergener K; Fäcke M; Welker R; Brinkmann V; Gelderblom HR; Kräusslich HG
    Virology; 1992 Jan; 186(1):25-39. PubMed ID: 1727601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
    Quillent C; Borman AM; Paulous S; Dauguet C; Clavel F
    Virology; 1996 May; 219(1):29-36. PubMed ID: 8623542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles.
    Wyma DJ; Kotov A; Aiken C
    J Virol; 2000 Oct; 74(20):9381-7. PubMed ID: 11000206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells.
    Lambert DM; Petteway SR; McDanal CE; Hart TK; Leary JJ; Dreyer GB; Meek TD; Bugelski PJ; Bolognesi DP; Metcalf BW
    Antimicrob Agents Chemother; 1992 May; 36(5):982-8. PubMed ID: 1510424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.